Divergent evidence requirements for authorization and reimbursement of high-risk medical devices - The European situation

L.J. Krüger^*
, S.M.A.A. Evers
, M. Hiligsmann
, C. Wild

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Sort by

Keyphrases

INIS

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science